Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × ricolinostat × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Recurrence 2 Disease Progression 1 Disease 1

Interventions

Dexamethasone 6 Lenalidomide 4 Cyclophosphamide 4 Melphalan 3 daratumumab 2 carfilzomib 2 Prednisone 2 ricolinostat 1 pomalidomide 1 deltacortene 1 Thalidomide 1 Calcium Dobesilate 1 Bortezomib 1 Bone Marrow Examination 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02189343 2019-11-21

Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma

Celgene

Phase 1 Completed

Disease, Multiple Myeloma, Recurrence, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡